Networks of myelin covariance in relapsing-remitting multiple sclerosis

被引:0
|
作者
Melie-Garcia, L. [1 ,2 ,3 ,4 ]
Barakovic, M. [1 ,2 ,3 ,4 ]
Weigel, M. [1 ,2 ,3 ,4 ,5 ]
Chen, X. [6 ]
Sanabria-Diaz, G. [6 ]
Galbusera, R. [1 ,2 ,3 ,4 ]
Lu, P. -J. [1 ,2 ,3 ,4 ]
Cagol, A. [1 ,2 ,3 ,4 ]
Schaedelin, S. [1 ,7 ]
Benkert, P. [1 ,7 ]
Lutti, A. [8 ,9 ]
Ruberte, E. [10 ]
Radue, E. -W. [1 ,2 ]
Kappos, L. [1 ,2 ,3 ,4 ]
Kuhle, J. [1 ,3 ,4 ]
Granziera, C. [1 ,2 ,3 ,4 ]
机构
[1] Univ Hosp Basel, Basel, Switzerland
[2] Univ Basel, Translat Imaging Neurol ThINK Basel, Dept Med & Biomed Engn, Basel, Switzerland
[3] Univ Basel, Neurol Clin & Policlin, MS Ctr, Basel, Switzerland
[4] Univ Basel, Res Ctr Clin Neuroimmunol & Neurosci Basel RC2NB, Basel, Switzerland
[5] Univ Hosp Basel, Div Radiol Phys, Dept Radiol, Basel, Switzerland
[6] Univ Basel, Translat Imaging Neurol ThINK, Dept Biomed Engn, Basel, Switzerland
[7] Univ Basel, Clin Trial Unit, Dept Clin Res, Basel, Switzerland
[8] Lausanne Univ Hosp, Lausanne, Switzerland
[9] Univ Lausanne, Lab Res Neuroimaging, Dept Clin Neurosci, Lausanne, Switzerland
[10] MIAC, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P192
引用
收藏
页码:257 / 258
页数:2
相关论文
共 50 条
  • [41] Thalamic neurodegeneration in relapsing-remitting multiple sclerosis
    Wylezinska, M
    Cifelli, A
    Jezzard, P
    Palace, J
    Alecci, M
    Matthews, PM
    NEUROLOGY, 2003, 60 (12) : 1949 - 1954
  • [42] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    JOURNAL OF NEUROLOGY, 2014, 261 : S303 - S303
  • [43] Postural Control in Relapsing-Remitting Multiple Sclerosis
    Cusin, Flavia Salvaterra
    Tomaz, Andreza
    Gananca, Mauricio Malavasi
    Oliveira, Enedina Maria
    Falcao Goncalves, Alessandra Billi
    Caovilla, Heloisa Helena
    INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2022, 26 (04) : 592 - 604
  • [44] Therapeutic inertia in relapsing-remitting multiple sclerosis
    Rodrigues, R.
    Rocha, R.
    Bonifacio, G.
    Ferro, D.
    Sabenca, F.
    Goncalves, A. I.
    Correia, F.
    Pinheiro, J.
    Loureiro, J. L.
    Guerreiro, R. P.
    Vale, J.
    Sa, M. J.
    Costa, A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 557 - 558
  • [45] Disability trajectories in relapsing-remitting multiple sclerosis
    Uher, T.
    Horakova, D.
    Havrdova, E. Kubala
    Izquierdo, G.
    Eichau, S.
    Patti, F.
    Prat, A. P.
    Girard, M.
    Duquette, P.
    Grammond, P.
    Onofrj, M.
    Lugaresi, A. L.
    Bergamaschi, R.
    Ozakbas, S.
    Grand'Maison, F.
    Hupperts, R.
    Sola, P.
    Ferraro, D.
    Sa, M. J.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 813 - 814
  • [46] Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis
    Grau-Lopez, L.
    Raich, D.
    Ramo-Tello, C.
    Naranjo-Gomez, M.
    Davalos, A.
    Pujol-Borrell, R.
    Borras, F. E.
    Martinez-Caceres, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (08) : 1101 - 1104
  • [47] Current management of relapsing-remitting multiple sclerosis
    Sedal, L.
    Wilson, I. B.
    McDonald, E. A.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (10) : 950 - 957
  • [48] Considerations in the treatment of relapsing-remitting multiple sclerosis
    Calabresi, PA
    NEUROLOGY, 2002, 58 (08) : S10 - S22
  • [49] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis
    Miller, Aaron E.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 181 - 194
  • [50] Teriflunomide: A Review in Relapsing-Remitting Multiple Sclerosis
    Scott, Lesley J.
    DRUGS, 2019, 79 (08) : 875 - 886